The US Food and Drug Administration (FDA) approved an implanted phrenic nerve-stimulator device as a new treatment for moderate-to-severe central sleep apnea (CSA).
FDA approves new phrenic nerve stimulator for central sleep apnea
FDA approves new phrenic nerve stimulator for…
FDA approves new phrenic nerve stimulator for central sleep apnea
The US Food and Drug Administration (FDA) approved an implanted phrenic nerve-stimulator device as a new treatment for moderate-to-severe central sleep apnea (CSA).